{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:18:00Z","timestamp":1770437880903,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2012.05.001","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T21:55:39Z","timestamp":1339192539000},"page":"e4-e14","source":"Crossref","is-referenced-by-count":40,"title":["Epidemiology, Pathophysiology, and Treatment of Hypertension in Ischaemic Stroke Patients"],"prefix":"10.1016","volume":"22","author":[{"given":"Nur Fatirul","family":"Hisham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulvi","family":"Bayraktutan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib1","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(00)04730-9","article-title":"The high cost of not funding stroke research: A comparison with heart disease and cancer","volume":"357","author":"Rothwell","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","article-title":"Classification and natural history of clinically identifiable subtypes of cerebral infarction","volume":"337","author":"Bamford","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1474-4422(09)70266-2","article-title":"Medical complications after stroke","volume":"9","author":"Kumar","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2009.02.334","article-title":"The neuroanatomical model of post-stroke depression: Towards a change of focus?","volume":"283","author":"Santos","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ageing\/afn281","article-title":"Cost of stroke in the United Kingdom","volume":"38","author":"Saka","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke. A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib7","series-title":"Textbook of stroke medicine.","year":"2010"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/01.STR.0000226604.10877.fc","article-title":"Long-term risk factors for stroke: Twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden","volume":"37","author":"Harmsen","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/diacare.28.2.355","article-title":"Epidemiology of ischemic stroke in patients with diabetes","volume":"28","author":"Kissela","year":"2005","journal-title":"Diabet Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib10","first-page":"1462","article-title":"2007 Guidelines for the management of arterial hypertension","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib11","first-page":"CR403","article-title":"Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000","volume":"11","author":"Qureshi","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1440-1681.1999.03081.x","article-title":"Hypertension mechanisms causing stroke","volume":"26","author":"Johansson","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.scds.2003.00.029","article-title":"Hypertension and cerebrovascular disease","volume":"3","author":"Jones","year":"2003","journal-title":"Sem Cerebrovasc Dis Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1161\/01.CIR.102.17.2087","article-title":"Independent association of high blood pressure and aortic atherosclerosis: A population-based study","volume":"102","author":"Agmon","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib15","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.athoracsur.2007.02.020","article-title":"The topography of aortic atherosclerosis enhances its precision as a predictor of stroke","volume":"83","author":"van der Linden","year":"2007","journal-title":"Ann Thoracic Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib16","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1161\/str.32.10.2265","article-title":"Hypertension status is the major determinant of carotid atherosclerosis: A community-based study in Taiwan","volume":"32","author":"Su","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/hs0102.102009","article-title":"Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population","volume":"33","author":"Lernfelt","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib18","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1161\/01.CIR.0000018650.58984.75","article-title":"Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: The Rotterdam study","volume":"105","author":"Hollander","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.21549","article-title":"Lacunar stroke is associated with diffuse blood\u2013brain barrier dysfunction","volume":"65","author":"Wardlaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib20","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1161\/STROKEAHA.107.491621","article-title":"Vascular permeability precedes spontaneous intracerebral hemorrhage in stroke-prone spontaneously hypertensive rats","volume":"38","author":"Lee","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-8993(00)02954-1","article-title":"Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells","volume":"885","author":"Lippoldt","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1242\/jcs.107.5.1347","article-title":"Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes","volume":"107","author":"Wolburg","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-3806(96)00117-4","article-title":"Development of blood-brain barrier tight junctions in the rat cortex","volume":"96","author":"Kniesel","year":"1996","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjhyper.2005.06.023","article-title":"Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function","volume":"19","author":"Ishida","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(03)02632-5","article-title":"Effect of hypertension on the integrity of blood brain and blood CSF barriers, cerebral blood flow and CSF secretion in the rat","volume":"975","author":"Al-Sarraf","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib28","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1161\/CIRCULATIONAHA.107.181486","volume":"115","author":"Adams","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11906-007-0092-5","article-title":"Management of hypertension in the setting of acute ischemic stroke","volume":"9","author":"Heitsch","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","article-title":"Guidelines for the early management of patients with ischemic stroke: A scientific statement from the stroke council of the American Stroke Association","volume":"34","author":"Adams","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.scds.2003.00.025","article-title":"Antihypertensive treatment and prevention of stroke and dementia","volume":"3","author":"Wang","year":"2003","journal-title":"Semin Cerebrovasc Dis Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0149-2918(04)90065-3","article-title":"Prevention and treatment of stroke in patients with hypertension","volume":"26","author":"Mancia","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib33","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","volume":"113","author":"Sacco","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib34","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0196-9781(00)00346-6","article-title":"Stroke: Development, prevention and treatment with peptidaseinhibitors","volume":"21","author":"Mark","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pharmthera.2005.05.006","article-title":"Pharmacological treatment of ischemic stroke","volume":"108","author":"Bentley","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib36","first-page":"1175","article-title":"Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: The study on cognition and prognosis in the elderly (SCOPE)","volume":"44","author":"Papademetriou","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib37","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.clinthera.2006.06.002","article-title":"Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension","volume":"28","author":"Diez","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.606962","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11883-010-0157-9","article-title":"The role of beta-blockers as first-line therapy in hypertension","volume":"13","author":"De Caterina","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/080370501753400665","article-title":"Beta-adrenergic blocking drugs in the treatment of hypertension","volume":"10","author":"Prichard","year":"2001","journal-title":"Blood Press"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib41","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.amjcard.2009.12.068","article-title":"Why beta-blockers should not be used as first choice in uncomplicated hypertension","volume":"105","author":"De Caterina","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib42","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","article-title":"Should beta\u00a0blockers remain as first choice in the treatment of primary hypertension? A meta-analysis","volume":"366","author":"Lindholm","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib43","doi-asserted-by":"crossref","first-page":"17J","DOI":"10.1016\/j.amjcard.2007.05.010","article-title":"Prevention of stroke in patients with hypertension","volume":"100","author":"Dahl\u00f6f","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib44","doi-asserted-by":"crossref","first-page":"F33","DOI":"10.1093\/eurheartj\/sup026","article-title":"Prevention of stroke: New evidence","volume":"11","author":"Dahl\u00f6f","year":"2009","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib46","first-page":"e274","article-title":"Effect of telmisartan on cognitive decline following stroke: PRoFESS cognitive sub-study","volume":"40","author":"Ford","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib47","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1097\/01.hjh.0000251902.85675.7e","article-title":"Angiotensin II\/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase","volume":"24","author":"Savoia","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/HYPERTENSIONAHA.108.126524","article-title":"Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats","volume":"53","author":"Mukaddam-Daher","year":"2009","journal-title":"Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib49","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.apmr.2007.08.089","article-title":"Antihypertensive efficacy and cerebral hemodynamic advantage of olmesartan medoxomil compared with amlodipine in poststroke patients [poster 56]","volume":"88","author":"Matsumoto","year":"2007","journal-title":"Arch Phys Med Rehab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib50","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1093\/eurheartj\/sup033","article-title":"The rationale for choosing telmisartan and ramipril in the ONTARGET programme","volume":"11","author":"Unger","year":"2009","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib51","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1093\/eurheartj\/sup032","article-title":"Clinical evidence from ONTARGET: Proven cardio- and vascular protection","volume":"11","author":"Teo","year":"2009","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib52","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","article-title":"The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: An analysis of the valsartan in acute myocardial infarction trial (VALIANT)","volume":"47","author":"McMurray","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1472-8206.2008.00570.x","article-title":"Stroke secondary prevention and blood pressure reduction: An observational study of the use of PROGRESS therapy","volume":"22","author":"Bugnicourt","year":"2008","journal-title":"Fund Clin Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib54","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of\u00a0a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib55","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/eurheartj\/ehp103","article-title":"The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: A combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials","volume":"30","author":"Brugts","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/08037050903513497","article-title":"Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC)","volume":"1","author":"Hasegawa","year":"2010","journal-title":"Blood Press Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib58","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/eurheartj\/ehm017","article-title":"Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients","volume":"28","author":"Gianni","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib59","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.107.089763","article-title":"Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: A quantitative overview","volume":"50","author":"Wang","year":"2007","journal-title":"Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib61","first-page":"CD003654","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","volume":"8","author":"Chen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/CS20010045","article-title":"Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery","volume":"101","author":"Stanton","year":"2001","journal-title":"Clin Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib63","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.48.2158","article-title":"Comparison of the anti-hypertensive effects of the L\/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease","volume":"48","author":"Takei","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib64","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0895-7061(04)00863-5","article-title":"Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects","volume":"17","author":"Angeli","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib65","first-page":"CD001841","article-title":"First-line drugs for hypertension","volume":"3","author":"Wright","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib66","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1097\/01.hjh.0000383858.34243.91","article-title":"Combination therapy in hypertension: Where do we stand","volume":"28","author":"Laurent","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jns.2009.02.335","article-title":"Nicardipine use in cerebrovascular disease: A review of controlled clinical studies","volume":"283","author":"Amenta","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2007.10.072","article-title":"Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats","volume":"580","author":"Matsubara","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib69","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archneur.1993.00540080060015","article-title":"Should hypertension be treated after acute stroke? A randomised controlled trial using single photon emission computed tomography","volume":"50","author":"Lisk","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.hjh.0000209990.41304.43","article-title":"Hypertension after cerebral ischemia: Candesartan provides neurovascular protection","volume":"24","author":"Fagan","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib71","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/jpet.108.139618","article-title":"Vascular protection with candesartan after experimental acute stroke in hypertensive rats: A dose-response study","volume":"326","author":"Kozak","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib72","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000108483","article-title":"Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke","volume":"4","author":"Wahlgren","year":"1994","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib74","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.STR.31.6.1250","article-title":"Effect of intravenous nimodipine on blood pressure and outcome after acute stroke","volume":"31","author":"Ahmed","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib75","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2796.2001.00831.x","article-title":"High initial blood pressure after acute stroke is associated with poor functional outcome","volume":"249","author":"Ahmed","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1747-4949.2006.00059.x","article-title":"Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122)","volume":"1","year":"2006","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.05.001_bib77","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(08)70069-3","article-title":"Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial","volume":"7","author":"Anderson","year":"2008","journal-title":"Lancet Neurol"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305712001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305712001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T02:55:26Z","timestamp":1642388126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305712001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1052305712001140"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2012.05.001","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}